Republican Senator Chuck Grassley urged a group of voters in Iowa to sell $35 for insulin, part of a larger prescription drug package. He said he supported the upper bound. A healthcare legislative package aimed at reducing monthly out-of-pocket drug costs for millions of Americans with diabetes.
However, he voted against the proposal earlier this month.
The cap was originally included in Congressional Democrats' Inflation Reduction Act,a major part of President Joe Biden'sdomestic agenda. This bill is aimed at andamong others. Lower the cost of prescription drugs. An intraparty vote was passed in the Senate, with all Republicans voting against.
In a video shared by the Iowa Starting Line on August 17, Sen. Grassley said he was "in favor of a $35 cap," saying capping insulin costs would We argue that it does not limit the role of pharmacy benefit managers, the companies that manage pharmaceuticals. He price benefits on behalf of health insurance companies and federal and state level plans.
Starting next year, the Reducing Inflation Act will limit monthly insulin copayments for Medicare beneficiaries to $35, while also reducing co-payments for older Americans with federal health program insurance. We limit our contributions to $2,000.
The Democrats advanced the bill through a budget adjustment, a process passed by a simple majority in an evenly divided Senate.
Through that process, however, the Senate, the unelected official directing the rule, established that broader insulin caps for non-Medicare patients could not be included. Lawmakers sought a majority of 60 votes to pass an amendment to include non-Medicare patients in the bill, but the provision fell short by votes of 57 to 32. Only seven Republicans joined the Democrats in supporting that amendment.
Senator Grassley voted against.
He supported an earlier amendment by Louisiana Republican Senator John Neely Kennedy. This would provide discounted insulin only to a limited pool of low-income patients through federally-backed clinics.
Senator Grassley was one of his 50 Republicans in the Senate who voted against the final version of bill on August 7.
"The bill had the chance to limit insulin to $35 for everyone, but it didn't pass.
"I have private health insurance. For some people, it would have been the ceiling," he replied. ``It would have been of no use to the uninsured.''
``But it would have been something,'' said the member.
